Literature DB >> 19213966

Differentiating suicide from life-ending acts and end-of-life decisions: a model based on chronic kidney disease and dialysis.

John Michael Bostwick1, Lewis M Cohen.   

Abstract

BACKGROUND: Technological advances continue to yield life-prolonging treatments that complicate the occurrence of death. Until recently, refusal to submit to recommended care was considered suicide.
OBJECTIVE: Physicians must now decide how to respond to requests for hastened dying.
METHOD: The authors propose a four-square grid distinguishing true suicide from behaviors such as treatment termination and lethal noncompliance.
RESULTS: One axis characterizes whether actions hasten death. The other identifies how the patient's social and medical network collaborate in the decision-making process.
CONCLUSION: Using chronic kidney disease to model intent and collaboration, treatment is framed within a paradigm that reflects both end-of-life decision-making complexities and contemporary conceptualizations of suicide.

Entities:  

Mesh:

Year:  2009        PMID: 19213966     DOI: 10.1176/appi.psy.50.1.1

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  3 in total

1.  Anxiety, depression and suicidal ideation in Lebanese patients undergoing hemodialysis.

Authors:  Gabrielle Macaron; Mario Fahed; Dany Matar; Rami Bou-Khalil; Francois Kazour; Dania Nehme-Chlela; Sami Richa
Journal:  Community Ment Health J       Date:  2013-12-13

2.  When Suicide Is Not Suicide: Self-induced Morbidity and Mortality in the General Hospital.

Authors:  J Michael Bostwick
Journal:  Rambam Maimonides Med J       Date:  2015-04-29

Review 3.  A systematic review of physical illness, functional disability, and suicidal behaviour among older adults.

Authors:  Madeleine Mellqvist Fässberg; Gary Cheung; Silvia Sara Canetto; Annette Erlangsen; Sylvie Lapierre; Reinhard Lindner; Brian Draper; Joseph J Gallo; Christine Wong; Jing Wu; Paul Duberstein; Margda Wærn
Journal:  Aging Ment Health       Date:  2015-09-18       Impact factor: 3.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.